PHILIP J. YOUNG

Corporate Board Profile

Tech Score: 0/100

Armata Pharmaceuticals, Inc.

Filing Date	Source Excerpt
2014-04-30	Mr. Young is a U.S.-based long-time executive in the biopharmaceuticals industry. He is the former President and CEO of Osteologix, Inc., a global biopharmaceutical company... Mr. Young received a B.S. in Sociology with minors in Business and Psychology from James Madison University.
2014-11-25	The Board of Directors of the Company (other than Mr. Young) is presenting to the Company’s shareholders the proposal, contingent upon the passage of Proposal No. 2, that Mr. Young be removed from the Board without cause, effective immediately. The Board of Directors (other than Mr. Young) believes that removing Mr. Young from the Board effective immediately is in the best interests of the Company and its shareholders as Mr. Young no longer serves as President or Chief Executive Officer, and is not involved in the management of the Company.

Filing Date

Source Excerpt

2014-04-30

Mr. Young is a U.S.-based long-time executive in the biopharmaceuticals industry. He is the former President and CEO of Osteologix, Inc., a global biopharmaceutical company... Mr. Young received a B.S. in Sociology with minors in Business and Psychology from James Madison University.

2014-11-25

The Board of Directors of the Company (other than Mr. Young) is presenting to the Company’s shareholders the proposal, contingent upon the passage of Proposal No. 2, that Mr. Young be removed from the Board without cause, effective immediately. The Board of Directors (other than Mr. Young) believes that removing Mr. Young from the Board effective immediately is in the best interests of the Company and its shareholders as Mr. Young no longer serves as President or Chief Executive Officer, and is not involved in the management of the Company.

Data sourced from SEC filings. Last updated: 2025-10-11